Barker finds Peace at Aegate after Noon
This article was originally published in Scrip
Drug authentication company Aegate has appointed Michael Peace CEO, following the departure of Gary Noon. Mr Peace joins Aegate from Thomson Reuters, where he was head of Asia for the financial markets business, the global head of the research and asset management division at Reuters and CEO of Lipper, a Thomson Reuters company.
In addition, Dr Richard Barker, former director general of the Association of the British Pharmaceutical Industry, joins Aegate as senior advisor. Dr Barker is currently director of the Centre for Accelerating Medical Innovations and an advisor to a number of healthcare companies.